Notice Title

Consent to the Distribution of New Medicines

Publication Date
16 Sep 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go5150
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Apohealth Melatonin
Active Ingredient: Melatonin 2mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturers: Oman Pharmaceutical Products Company LLC, Salalah, Oman
Gracure Pharmaceuticals Limited, Bhiwadi, India
 
Product: Melotin
Active Ingredient: Melatonin 2mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturers: Oman Pharmaceutical Products Company LLC, Salalah, Oman
Gracure Pharmaceuticals Limited, Bhiwadi, India
 
Product: Vigisom
Active Ingredient: Melatonin 2mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Rovi Pharma Industrial Services, S.A., Madrid, Spain
SwissCo Services AG, Sisseln, Switzerland
Iberfar – Industria Farmaceutica S.A., Barcarena, Portugal


Dated this 11th day of September 2025.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).